Defective presentation of the CD1d1-restricted natural Va14Ja18 NKT lymphocyte antigen caused by β-D-glucosylceramide synthase deficiency

Aleksandar K. Stanic, A. Dharshan De Silva, Jang June Park, Venkataraman Sriram, Shinichi Ichikawa, Yoshio Hirabyashi, Kyoko Hayakawa, Luc Van Kaer, Randy Brutkiewicz, Sebastian Joyce

Research output: Contribution to journalArticle

125 Citations (Scopus)

Abstract

Va14Ja18 natural T (NKT) cells play an immunoregulatory role, which is controlled by a self glycolipid(s) presented by CDld. Although the synthetic antigen α-D-galactosylceramide (α-D-GalCer) stimulates all Va14Ja18 NKT cells, α-anomeric D-glycosylceramides are currently unknown in mammals. We have used β-D-GalCer-deficient mice and β-D-glucosylceramide (β-D-GlcCer)-deficient cells to define the chemical nature of a natural NKT cell antigen. β-D-GalCer-deficient mice exhibit normal NKT cell development and function, and cells from these animals potently stimulate NKT hybridomas. In striking contrast, the same hybridomas fail to react to CD1d1 expressed by a β-D-GlcCer-deficient cell line. Importantly, human β-D-GlcCer synthase cDNA transfer, and hence the biosynthesis of β-D-GlcCer, restores the recognition of mutant cells expressing CD1d1 by the Va14Ja18 NKT hybridomas. Additionally, suppression of β-D-GlcCer synthesis inhibits antigen presentation to Va14Ja18 NKT cells. The possibility that β-D-GlcCer itself is the natural NKT cell antigen was excluded because it was unable to activate NKT hybridomas in a cell-free antigen-presentation assay. These findings suggest that β-D-GlcCer may play an important role in generating and/or loading a natural Va14Ja18 NKT antigen.

Original languageEnglish
Pages (from-to)1849-1854
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume100
Issue number4
DOIs
StatePublished - Feb 18 2003

Fingerprint

ceramide glucosyltransferase
Natural Killer T-Cells
Hybridomas
Lymphocytes
Antigens
Antigen Presentation
Galactosylceramides
Glucosylceramides
Synthetic Vaccines
Glycolipids
Mammals
Complementary DNA
Cell Line

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Defective presentation of the CD1d1-restricted natural Va14Ja18 NKT lymphocyte antigen caused by β-D-glucosylceramide synthase deficiency. / Stanic, Aleksandar K.; De Silva, A. Dharshan; Park, Jang June; Sriram, Venkataraman; Ichikawa, Shinichi; Hirabyashi, Yoshio; Hayakawa, Kyoko; Van Kaer, Luc; Brutkiewicz, Randy; Joyce, Sebastian.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 100, No. 4, 18.02.2003, p. 1849-1854.

Research output: Contribution to journalArticle

Stanic, Aleksandar K. ; De Silva, A. Dharshan ; Park, Jang June ; Sriram, Venkataraman ; Ichikawa, Shinichi ; Hirabyashi, Yoshio ; Hayakawa, Kyoko ; Van Kaer, Luc ; Brutkiewicz, Randy ; Joyce, Sebastian. / Defective presentation of the CD1d1-restricted natural Va14Ja18 NKT lymphocyte antigen caused by β-D-glucosylceramide synthase deficiency. In: Proceedings of the National Academy of Sciences of the United States of America. 2003 ; Vol. 100, No. 4. pp. 1849-1854.
@article{f5a1ba89b87840569ef903b6b1d98664,
title = "Defective presentation of the CD1d1-restricted natural Va14Ja18 NKT lymphocyte antigen caused by β-D-glucosylceramide synthase deficiency",
abstract = "Va14Ja18 natural T (NKT) cells play an immunoregulatory role, which is controlled by a self glycolipid(s) presented by CDld. Although the synthetic antigen α-D-galactosylceramide (α-D-GalCer) stimulates all Va14Ja18 NKT cells, α-anomeric D-glycosylceramides are currently unknown in mammals. We have used β-D-GalCer-deficient mice and β-D-glucosylceramide (β-D-GlcCer)-deficient cells to define the chemical nature of a natural NKT cell antigen. β-D-GalCer-deficient mice exhibit normal NKT cell development and function, and cells from these animals potently stimulate NKT hybridomas. In striking contrast, the same hybridomas fail to react to CD1d1 expressed by a β-D-GlcCer-deficient cell line. Importantly, human β-D-GlcCer synthase cDNA transfer, and hence the biosynthesis of β-D-GlcCer, restores the recognition of mutant cells expressing CD1d1 by the Va14Ja18 NKT hybridomas. Additionally, suppression of β-D-GlcCer synthesis inhibits antigen presentation to Va14Ja18 NKT cells. The possibility that β-D-GlcCer itself is the natural NKT cell antigen was excluded because it was unable to activate NKT hybridomas in a cell-free antigen-presentation assay. These findings suggest that β-D-GlcCer may play an important role in generating and/or loading a natural Va14Ja18 NKT antigen.",
author = "Stanic, {Aleksandar K.} and {De Silva}, {A. Dharshan} and Park, {Jang June} and Venkataraman Sriram and Shinichi Ichikawa and Yoshio Hirabyashi and Kyoko Hayakawa and {Van Kaer}, Luc and Randy Brutkiewicz and Sebastian Joyce",
year = "2003",
month = "2",
day = "18",
doi = "10.1073/pnas.0430327100",
language = "English",
volume = "100",
pages = "1849--1854",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "4",

}

TY - JOUR

T1 - Defective presentation of the CD1d1-restricted natural Va14Ja18 NKT lymphocyte antigen caused by β-D-glucosylceramide synthase deficiency

AU - Stanic, Aleksandar K.

AU - De Silva, A. Dharshan

AU - Park, Jang June

AU - Sriram, Venkataraman

AU - Ichikawa, Shinichi

AU - Hirabyashi, Yoshio

AU - Hayakawa, Kyoko

AU - Van Kaer, Luc

AU - Brutkiewicz, Randy

AU - Joyce, Sebastian

PY - 2003/2/18

Y1 - 2003/2/18

N2 - Va14Ja18 natural T (NKT) cells play an immunoregulatory role, which is controlled by a self glycolipid(s) presented by CDld. Although the synthetic antigen α-D-galactosylceramide (α-D-GalCer) stimulates all Va14Ja18 NKT cells, α-anomeric D-glycosylceramides are currently unknown in mammals. We have used β-D-GalCer-deficient mice and β-D-glucosylceramide (β-D-GlcCer)-deficient cells to define the chemical nature of a natural NKT cell antigen. β-D-GalCer-deficient mice exhibit normal NKT cell development and function, and cells from these animals potently stimulate NKT hybridomas. In striking contrast, the same hybridomas fail to react to CD1d1 expressed by a β-D-GlcCer-deficient cell line. Importantly, human β-D-GlcCer synthase cDNA transfer, and hence the biosynthesis of β-D-GlcCer, restores the recognition of mutant cells expressing CD1d1 by the Va14Ja18 NKT hybridomas. Additionally, suppression of β-D-GlcCer synthesis inhibits antigen presentation to Va14Ja18 NKT cells. The possibility that β-D-GlcCer itself is the natural NKT cell antigen was excluded because it was unable to activate NKT hybridomas in a cell-free antigen-presentation assay. These findings suggest that β-D-GlcCer may play an important role in generating and/or loading a natural Va14Ja18 NKT antigen.

AB - Va14Ja18 natural T (NKT) cells play an immunoregulatory role, which is controlled by a self glycolipid(s) presented by CDld. Although the synthetic antigen α-D-galactosylceramide (α-D-GalCer) stimulates all Va14Ja18 NKT cells, α-anomeric D-glycosylceramides are currently unknown in mammals. We have used β-D-GalCer-deficient mice and β-D-glucosylceramide (β-D-GlcCer)-deficient cells to define the chemical nature of a natural NKT cell antigen. β-D-GalCer-deficient mice exhibit normal NKT cell development and function, and cells from these animals potently stimulate NKT hybridomas. In striking contrast, the same hybridomas fail to react to CD1d1 expressed by a β-D-GlcCer-deficient cell line. Importantly, human β-D-GlcCer synthase cDNA transfer, and hence the biosynthesis of β-D-GlcCer, restores the recognition of mutant cells expressing CD1d1 by the Va14Ja18 NKT hybridomas. Additionally, suppression of β-D-GlcCer synthesis inhibits antigen presentation to Va14Ja18 NKT cells. The possibility that β-D-GlcCer itself is the natural NKT cell antigen was excluded because it was unable to activate NKT hybridomas in a cell-free antigen-presentation assay. These findings suggest that β-D-GlcCer may play an important role in generating and/or loading a natural Va14Ja18 NKT antigen.

UR - http://www.scopus.com/inward/record.url?scp=0037452710&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037452710&partnerID=8YFLogxK

U2 - 10.1073/pnas.0430327100

DO - 10.1073/pnas.0430327100

M3 - Article

C2 - 12576547

AN - SCOPUS:0037452710

VL - 100

SP - 1849

EP - 1854

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 4

ER -